[ASND] YoY Quarter Result on 30-Sep-2023 [#Q3]

Stock
[ASND] Ascendis Pharma A/S
Announcement Date
29-Sep-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -33.59%
YoY- 3.98%
Quarter Report
ASND's Result
ASND's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Revenue 48,034 15,290 1,113 2,757 2,243 20 434 119.03%
PBT -161,578 -169,122 -80,343 -121,760 -25,174 -34,067 -34,117 29.57%
Tax 645 -167 5 -19 -61 -100 -240 -
NP -162,223 -168,955 -80,348 -121,741 -25,113 -33,967 -33,877 29.81%
Tax Rate - - - - - - - -
Total Cost 210,257 184,245 81,461 124,498 27,356 33,987 34,311 35.25%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
NP Margin -337.73 -1,105.00 -7,219.05 -4,415.71 -1,119.62 -169,835.00 -7,805.76 -40.73%
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
EPS -2.88 -3.03 -1.47 -2.31 -0.53 -0.81 -1.04 18.49%
EPS Diluted -2.88 -3.03 -1.47 -2.31 -0.53 -0.81 -1.04 18.49%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.